tiprankstipranks
Trending News
More News >

Diaceutics Reports Strong FY 2024 Results with Significant Growth and Expansion

Story Highlights
  • Diaceutics achieved 39% revenue growth and 50% EBITDA increase in FY 2024.
  • The company expanded in the US and secured new enterprise engagements, positioning for 2025 growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Diaceutics Reports Strong FY 2024 Results with Significant Growth and Expansion

Confident Investing Starts Here:

The latest announcement is out from Diaceutics ( (GB:DXRX) ).

Diaceutics PLC reported strong financial and commercial performance for FY 2024, with a 39% revenue growth to £32.2 million and a 50% increase in adjusted EBITDA to £4.2 million. The company expanded its sales presence in the US and launched its PMx solution, contributing to its growth momentum. With an order book of £24.9 million and an ARR of £16.8 million, Diaceutics is positioned for continued growth in 2025. The company secured three new enterprise-wide engagements and increased its customer base, working with 18 of the top 20 global pharma companies. Despite macroeconomic uncertainties, Diaceutics remains confident in achieving its growth and profitability targets for 2025.

The most recent analyst rating on (GB:DXRX) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Diaceutics stock, see the GB:DXRX Stock Forecast page.

More about Diaceutics

Diaceutics is a leading technology and solutions provider to the pharma and biotech industry, offering an end-to-end commercialization solution for precision medicines through data analytics, scientific and advisory services enabled by their platform DXRX – The Diagnostics Network®. The company focuses on ensuring that patients receive the right tests and therapies to positively impact their disease outcomes.

Average Trading Volume: 84,642

Technical Sentiment Signal: Hold

Current Market Cap: £102.7M

Learn more about DXRX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App